Cargando…
Veverimer: an advance in base therapy for metabolic acidosis
Autores principales: | Brady, Clayton, Chemaly, Elie R., Lohr, James W., Parker, Mark D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661860/ https://www.ncbi.nlm.nih.gov/pubmed/33209911 http://dx.doi.org/10.21037/atm-20-2827 |
Ejemplares similares
-
Veverimer for treatment of chronic metabolic acidosis in patients with chronic kidney disease
por: Gone, Anirudh R., et al.
Publicado: (2020) -
Effects of Veverimer in Older Adults With CKD and Metabolic Acidosis
por: Tangri, Navdeep, et al.
Publicado: (2021) -
Efficacy and Safety of Veverimer in the Treatment of Metabolic Acidosis Caused by Chronic Kidney Disease: A Meta-analysis
por: Liu, Wenlin, et al.
Publicado: (2021) -
Effects of veverimer on serum bicarbonate and physical function in women with chronic kidney disease and metabolic acidosis: a subgroup analysis from a randomised, controlled trial
por: Mathur, Vandana S., et al.
Publicado: (2022) -
Effects of veverimer on serum bicarbonate and physical function in diabetic patients with chronic kidney disease and metabolic acidosis: subgroup analysis from a randomized, controlled trial
por: Mathur, Vandana S, et al.
Publicado: (2021)